The incidence of thrombocytopenia associated with continuous renal replacement therapy in critically ill patients

Renal Failure

Volumn 37, Issue 7, 2015, Pages 1232-1236

  Ferreira, Jason A ^a   Johnson, Donald W ^a  

^a UNIVERSITY OF FLORIDA HEALTH JACKSONVILLE   (United States)

Author keywords

Continuous renal replacement; heparin induced thrombocytopenia; renal replacement therapy; thrombocytopenia

Indexed keywords

HEPARINOID; ANTICOAGULANT AGENT; HEPARIN;

ACUTE KIDNEY FAILURE; ADULT; ANTICOAGULANT THERAPY; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENT; FEMALE; HEALTH CARE; HEPARINIZATION; HUMAN; INTENSIVE CARE UNIT; MALE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; ACUTE KIDNEY INJURY; AGED; CRITICAL ILLNESS; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY;

ACUTE KIDNEY INJURY; AGED; ANTICOAGULANTS; BLOOD PLATELETS; CRITICAL ILLNESS; FEMALE; HEPARIN; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 84941904594     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2015.1057799     Document Type: Article

References (13)

1. Holmes CE, Huang JC, Cartelli C, Howard A, Rimmer J, Cushman M. The clinical diagnosis of heparin-induced thrombocytopenia in patients receiving continuous renal replacement therapy. J Thromb Thrombolysis. 2009;27:406-412.
2. Posadas MA, Hahn D, Schleuter W, Paparello J. Thrombocytopenia associated with dialysis treatments. Hemodial Int. 2011;15: 416-423.
3. Cheung PY, Sawicki G, Salas E, Etches PC, Schulz R, Radomski MW. The mechanism of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates. Crit Care Med. 2000;28(7):2584-2590.
4. Warkentin TE, Greinacher A. Heparin induced thrombocytopenia recognition, treatment, and prevention. Chest. 2004;126: 311S-337S.
5. Schilder L, Nurmohamed S, Bosch F, et al. Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury a multi-center randomized clinical trial. Crit Care. 2014; 18:472.
6. Oudemans-Van Straaten HM, Bosman RJ, Koopmans M, et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med. 2009;37(2):545-552.
7. Hetzel GR, Schmitz M, Wissing H, et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous hemofiltration: A prospective randomized multicentre trial. Nephrol Dial Transplant. 2011:26:232-239.
8. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low molecular weight heparin thromboprophylaxis: A meta-analysis. Blood. 2005;106: 2710-2715.
9. Linkins LA, Dans AL, Moores LK, et al. Treatment and prevention of heparin induced thrombocytopenia. Antithrombotic therapy and prevention of thrombosis 9th ed: American college of chest physicians evidence based clinical practice guidelines. Chest. 2012;141(2 suppl):e495S-e530S.
10. Liu S, Shi W, Liang X, et al. Celluloase triacetate dialyzer reduces platelet loss during continuous veno-venous hemofiltration. Blood Purif. 2010;29(4):375-382.
11. Wu M, Hsu Y, Bai C, Lin Y, Wu C, Tam K. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: A meta-analysis of randomized controlled trials. Am J Kidney Dis. 2012;59(6):810-818.
12. Mulder J, Tan HK, Bellomo R, Silvester W. Platelet loss across the hemofilter during continuous hemofiltration. Int J Artif Organs. 2003;10:906-912.
13. Oever GD, Schoorl M, Schrool M, Bartels PCM, Grooteman MPC, Nube MJ. The role of the extracorporeal circuit in the trapping and degranulation of platelets. Blood Purif. 2009;28:253-259.